Related Experiment Video
Updated: Apr 1, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Allergic rhinitis and associated risk of migraine among children: a nationwide population-based cohort study
I-Chung Wang1, Jeng-Dau Tsai2,3, Cheng-Li Lin4,5
1Children's Hospital, China Medical University Hospital, Taichung, Taiwan.
Insights
Children with allergic rhinitis (AR) have a significantly higher risk of developing migraine. This study highlights the need for increased physician awareness of migraine symptoms in children diagnosed with AR.
Area of Science:
- Pediatric Neurology
- Allergy and Immunology
- Epidemiology
Background:
- Allergic rhinitis (AR) is linked to increased migraine frequency in adults.
- Migraine can affect children and persist into adulthood.
Purpose of the Study:
- To investigate the incidence and risk of migraine in children diagnosed with allergic rhinitis (AR).
Main Methods:
- A population-based cohort study included 461,850 children with AR and 460,718 controls from 2000-2007.
- Migraine incidence, hazard ratios (HRs), and confidence intervals (CIs) were measured by the end of 2008.
Main Results:
- Children with AR showed a 3.2-fold higher migraine incidence (11.4 per 10,000 person-years) versus controls (3.49 per 10,000 person-years).
- The risk was elevated in boys, children under 6, and those with more frequent AR-related medical visits (HR 14.8 for >4 visits).
- Highest migraine risk occurred within the first year post-AR diagnosis (HR 4.89), with a higher likelihood of migraine without aura.
Conclusions:
- Children with AR exhibit a greater incidence and subsequent risk of migraine.
- Healthcare providers should maintain heightened awareness for migraine symptoms in pediatric patients with AR.
Background:
Increased frequency of migraine was reported in adults with allergic rhinitis (AR). Although migraine is less common in children than in adults, it can begin in early childhood and persist into adulthood. We conducted this population-based cohort study to investigate the incidence and subsequent risk of migraine in children with AR.
Methods:
From 2000 to 2007, 461,850 children with recently diagnosed AR and 460,718 non-AR controls were included in the study. By the end of 2008, incidences of migraine in both cohorts, the AR to non-AR cohort hazard ratios (HRs), and confidence intervals (CIs) were measured.
Results:
The incidence of migraine during the study period was 3.2-fold higher in the AR cohort (95% CI, 2.97 to 3.46) than in the non-AR cohort (11.4 vs 3.49 per 10000 person-years). The risk was greater for boys than for girls, and for children aged <6 years. The HR for migraine in children with AR was 1.44 (95% CI, 1.31 to 1.58) for those with ≤2 annual AR-related medical visits, whereas, 14.8 (95% CI, 13.6 to 16.2) for those with >4 visits (p < 0.0001, the trend test). The risk of migraine development in the AR cohort was highest within the first year after AR diagnosis (HR 4.89; 95% CI, 3.98 to 6.00). Children with AR were more likely to have migraine without aura than migraine with aura.
Conclusion:
Children with AR had a higher incidence and subsequent risk of migraine. Physicians should be more aware of migraine in children with AR who complain of headache.
More Related Videos
Related Concept Videos
Asthma-I: Introduction
Allergic Reactions
Allergic Reactions: Anaphylaxis
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

